Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.

Cell | 2021

T cells are critical effectors of cancer immunotherapies, but little is known about their gene expression programs in diffuse gliomas. Here, we leverage single-cell RNA sequencing (RNA-seq) to chart the gene expression and clonal landscape of tumor-infiltrating T cells across 31 patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma and IDH mutant glioma. We identify potential effectors of anti-tumor immunity in subsets of T cells that co-express cytotoxic programs and several natural killer (NK) cell genes. Analysis of clonally expanded tumor-infiltrating T cells further identifies the NK gene KLRB1 (encoding CD161) as a candidate inhibitory receptor. Accordingly, genetic inactivation of KLRB1 or antibody-mediated CD161 blockade enhances T cell-mediated killing of glioma cells in vitro and their anti-tumor function in vivo. KLRB1 and its associated transcriptional program are also expressed by substantial T cell populations in other human cancers. Our work provides an atlas of T cells in gliomas and highlights CD161 and other NK cell receptors as immunotherapy targets.

Pubmed ID: 33592174 RIS Download

Additional research tools detected in this publication

Antibodies used in this publication

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA227156
  • Agency: NCI NIH HHS, United States
    Id: R01 CA227821
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NCI NIH HHS, United States
    Id: P30 CA014051
  • Agency: NCI NIH HHS, United States
    Id: K12 CA090354
  • Agency: NCI NIH HHS, United States
    Id: R21 CA220253
  • Agency: NCI NIH HHS, United States
    Id: R33 CA202820
  • Agency: NCI NIH HHS, United States
    Id: P50 CA165962
  • Agency: NCI NIH HHS, United States
    Id: R01 CA234018
  • Agency: NCI NIH HHS, United States
    Id: U19 CA264504
  • Agency: NCI NIH HHS, United States
    Id: U24 CA180922
  • Agency: NCI NIH HHS, United States
    Id: R01 CA238039
  • Agency: NCI NIH HHS, United States
    Id: P01 CA236749
  • Agency: NCI NIH HHS, United States
    Id: R01 CA251599
  • Agency: NCI NIH HHS, United States
    Id: R37 CA245523
  • Agency: NCI NIH HHS, United States
    Id: R01 CA244975
  • Agency: NIDDK NIH HHS, United States
    Id: RC2 DK116691
  • Agency: NCI NIH HHS, United States
    Id: L30 CA231679

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BD FACSDiva Software (tool)

RRID:SCR_001456

A collection of tools for flow cytometer and application setup, data acquisition, and data analysis that help streamline flow cytometry workflows. It provides features to help users integrate flow systems into new application areas, including index sorting for stem cell and single-cell applications, as well as automation protocols for high-throughput and robotic laboratories.

View all literature mentions

TraCeR (tool)

RRID:SCR_016338

Software application for recovery of T cell receptor (TCR) data from single cell data. Used to reconstruct full-length, paired T cell receptor (TCR) sequences from T lymphocyte single-cell RNA sequence data. Links T cell specificity with functional response by revealing clonal relationships between cells alongside their transcriptional profiles.

View all literature mentions

Jurkat (tool)

RRID:CVCL_0065

Cell line Jurkat is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

PE/Cyanine7 anti-mouse CD3 (antibody)

RRID:AB_1732057

This monoclonal targets CD3

View all literature mentions

Purified anti-human CD161 (antibody)

RRID:AB_1501090

This monoclonal targets CD161

View all literature mentions

PE anti-human TIGIT (VSTM3) (antibody)

RRID:AB_2632730

This monoclonal targets TIGIT

View all literature mentions

FITC anti-human CD223 (LAG-3) (antibody)

RRID:AB_2629751

This monoclonal targets CD223

View all literature mentions

PE/Cyanine7 anti-human TNF-alpha (antibody)

RRID:AB_2204079

This monoclonal targets TNF-alpha

View all literature mentions

FITC anti-human IL-2 (antibody)

RRID:AB_315091

This monoclonal targets IL-2

View all literature mentions

PE anti-human Perforin (antibody)

RRID:AB_2616860

This monoclonal targets Perforin

View all literature mentions

PE anti-human CD107a (LAMP-1) (antibody)

RRID:AB_1186040

This monoclonal targets CD107a

View all literature mentions

Human NKp80/KLRF1 Phycoerythrin MAb (Clone 239127) (antibody)

RRID:AB_2249693

This monoclonal targets Human NKp80/KLRF1 Phycoerythrin MAb (Clone 239127)

View all literature mentions

CD159c (NKG2C) Antibody, anti-human, PE, REAfinity™ (antibody)

RRID:AB_2751835

This recombinant monoclonal targets CD159c (NKG2C)

View all literature mentions

APC anti-human CD279 (PD-1) (antibody)

RRID:AB_940475

This monoclonal targets CD279

View all literature mentions

APC anti-human CD163 (antibody)

RRID:AB_2074533

This monoclonal targets CD163

View all literature mentions

APC anti-human CD64 (antibody)

RRID:AB_1595428

This monoclonal targets CD64

View all literature mentions

APC anti-human CD14 (antibody)

RRID:AB_2566792

This monoclonal targets CD14

View all literature mentions

CD161 (antibody)

RRID:AB_2737678

This monoclonal targets CD161

View all literature mentions

CD3 (antibody)

RRID:AB_2738909

This monoclonal targets CD3

View all literature mentions

CD45 (antibody)

RRID:AB_2744402

This monoclonal targets CD45

View all literature mentions

J.RT3-T3.5 (cell line)

RRID:CVCL_1316

Cell line J.RT3-T3.5 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

NOD.Cg-Prkdcscid Il2rg/SzJ (organism)

RRID:IMSR_JAX:005557

Mus musculus with name NOD.Cg-Prkdcscid Il2rg/SzJ from IMSR.

View all literature mentions

GL261-luc2 (cell line)

RRID:CVCL_X986

Cell line GL261-luc2 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

Jurkat E6.1 (cell line)

RRID:CVCL_0367

Cell line Jurkat E6.1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions